Novartis pauses clinical trials for rap-cel in patients with autoimmune disease, while reporting positive data for a ...
Medtronic stock advances after the company posts better-than-expected quarterly earnings, raises revenue guidance, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results